Ceesun,
I did the Phase 1 trial of the DNA Plasmid Her2 vaccine. In addition to the following criteria, you had to pass a blood test (looked at some inflammatory marker, can't rememebr the details, but maybe Steph N will chime in)
I learned about the trial on this site and asked my onc about it. He highly encouraged me to enroll. U of W can not reimburse you for any expenses except parking. I used my frequent flyer miles for most of my trips to Seattle. I have listed some info from the U of W website for the trial I participated in (but like Debbie said, there are a few more trials now) I would hope your oncologist could give you some guidance on the best trial for you.
Patient Population- HER2-neu over-expressing
- Stage III & IV Breast Cancer
- NED or Stable bone-only disease
- Unable to bear children
Number of Patients: This study will accrue a maximum of 66 patients with 22 per dose level.
(Now accruing for the last dose level) Patients Visits
- Total of 7 visits to Seattle
- 1 Vaccination per month for 3 months
- Follow-up visits in months 4, 6, 9 & 15
- Yearly questionnaires to physician for up to 15 years
Other Procedures
- Tetanus Vaccine: done at first visist
- Tattoo: two small dots to mark the vaccination site
- Chest X-ray
- Skin Biopsy
- History & Physical
- Blood Tests
- MUGA or ECHO (depends on current tx)
- Research Blood Draws
__________________
Are we there yet?
Dx 10/05 IDC, multi-focal, triple +, 5 nodes+
MRM, 4 DD A/C, 12 weekly taxol + herceptin
rads concurrent with taxol/herceptin
finished herceptin 01/08
ooph, Arimidex, bilateral DIEP reconstruction
NED
Univ. of WA, Seattle vaccine trial '07
|